Benoxaprofen-induced photo-onycholysis.
Benoxaprofen (Opren) is a nonsteroidal anti-inflammatory agent used in the treatment of arthritis. Photosensitivity, including onycholysis, has been reported in the rheumatologic literature. This drug has recently been approved for use in the United States under the name of Oraflex. In order to alert the dermatology community, we report a case of photo-onycholysis which developed in a patient being treated with benoxaprofen and review the data on this drug and its side effects.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009260:Nail Diseases / Q000139:chemically induced*; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D011422:Propionates / Q000009:adverse effects*
D000893:Anti-Inflammatory Agents; D011422:Propionates; C011677:benoxaprofen